Category: ConMed Corp.
Here's a look at some of the top personnel stories for medical device companies this week.
The proxy war over control of the board of directors at ConMed gets ugly, with allegations of sexual harassment levied against 1 nominee.
UPDATED March 4, 2014, with comment from Coppersmith Capital.
The proxy war over control of the board at ConMed (NSDQ:CNMD) turned ugly this week after serious allegations surfaced against 1 of the medical device company's nominees for director.
ConMed accedes to the demands of a major shareholder, appointing a new chairman to replace founder Eugene Corasanti, who will leave the board entirely this year.
ConMed (NSDQ:CNMD) reached a deal with an institutional investor that owns a 6% stake in the medical device company that will see founder Eugene Corasanti step down as chairman, effective immediately.
FDA inspectors warn ConMed on violations at a Colorado manufacturing facility, including for handling of device-related injuries, risk analysis, complaint handling and more.
FDA regulators issued a formal warning letter to ConMed (NSDQ:CNMD) citing numerous violations observed during an inspection of the company's Colorado manufacturing facility.
Shares of ConMed are up today after the medical device company posted 4th-quarter and 2013 numbers that beat expectations.
ConMed (NSDQ:CNMD) shares ticked up today after the medical device company beat its own forecast and Wall Street's expectations with its 4th-quarter and 2013 results.
ConMed responds to a challenge from activist investor group Voce Capital Management, citing "the strong operating performance delivered by ConMed over the past several years."
ConMed (NSDQ:CNMD) today responded to a long and critical letter from Voce Capital Management issued last week that demanded steps toward a strategic exit and the end "a culture of nepotism, patronage and dystopian corporate governance."
Vocal shareholder advocate Voce Capital demands some major overhauls at New York medtech company ConMed amid a tough quarter and an ever-dimming outlook for the year.
Corrected November 11 2013, at 2:45 p.m.